Stockscreener 앱 받기
0.30
6.75%
-0.0217
시간 외 거래:
.30
전일 마감가:
$0.3217
열려 있는:
$0.35
하루 거래량:
419.50K
Relative Volume:
0.37
시가총액:
$27.37M
수익:
$9.53M
순이익/손실:
$-44.61M
주가수익비율:
-0.3297
EPS:
-0.91
순현금흐름:
$-38.32M
1주 성능:
-5.09%
1개월 성능:
-13.04%
6개월 성능:
-62.03%
1년 성능:
-77.44%
1일 변동 폭
$0.30
$0.35
1주일 범위
$0.30
$0.355
52주 변동 폭
$0.2302
$1.54
Cue Biopharma Inc Stock (CUE) Company Profile
명칭
Cue Biopharma Inc
전화
617-949-2680
주소
40 GUEST STREET, BOSTON, MA
Compare CUE vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CUE
Cue Biopharma Inc
|
0.30 | 29.35M | 9.53M | -44.61M | -38.32M | -0.91 |
|
VRTX
Vertex Pharmaceuticals Inc
|
465.02 | 117.03B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
783.65 | 82.35B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
833.54 | 51.64B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
308.48 | 42.58B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.42 | 38.87B | 4.98B | 69.60M | 525.67M | 0.5198 |
Cue Biopharma Inc Stock (CUE) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-03-13 | 개시 | Jefferies | Buy |
| 2023-06-26 | 재개 | Oppenheimer | Outperform |
| 2022-11-21 | 개시 | Piper Sandler | Overweight |
| 2022-01-13 | 개시 | H.C. Wainwright | Buy |
| 2022-01-03 | 개시 | Craig Hallum | Buy |
| 2020-11-24 | 개시 | Berenberg | Buy |
| 2020-04-09 | 개시 | Stifel | Buy |
| 2020-01-28 | 개시 | BTIG Research | Buy |
| 2020-01-22 | 개시 | JMP Securities | Mkt Outperform |
모두보기
Cue Biopharma Inc 주식(CUE)의 최신 뉴스
Cue Biopharma appoints industry veteran Lucinda Warren as chief financial and business officer - marketscreener.com
Cue Biopharma (CUE) Appoints New Chief Financial and Business Of - GuruFocus
Cue Biopharma, Inc. Appoints Lucinda Warren as Chief Financial Officer, Effective February 9, 2026 - marketscreener.com
Cue Biopharma Names Lucinda Warren Chief Financial Officer - TipRanks
Cue Biopharma Appoints Industry Veteran Lucinda Warren as Chief Financial and Business Officer - bitget.com
Can Cue Biopharma Inc outperform in the next rallyJuly 2025 Chart Watch & Daily Stock Momentum Reports - baoquankhu1.vn
What’s the RSI of Cue Biopharma Inc. stockQuarterly Growth Report & Reliable Breakout Forecasts - mfd.ru
Is Cue Biopharma Inc. stock forming a triangle pattern2025 Market WrapUp & AI Driven Stock Movement Reports - mfd.ru
Volatility Watch: Is Cue Biopharma Inc forming a bullish divergence2025 Price Targets & Weekly High Potential Stock Alerts - baoquankhu1.vn
CUE Stock Price, Forecast & Analysis | CUE BIOPHARMA INC (NASDAQ:CUE) - Chartmill
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
Biotech Stocks Surge After Hours: IO Biotech Jumps 19%, Cue Biopharma And Cabaletta Bio Follow - Nasdaq
Options Flow: Can Cue Biopharma Inc disrupt its industryMarket Risk Analysis & Risk Managed Investment Strategies - baoquankhu1.vn
Is Cue Biopharma Inc. (1UC) stock overpriced at current multiples2025 Trading Volume Trends & Growth Oriented Trading Recommendations - bollywoodhelpline.com
Is Cue Biopharma Inc benefiting from interest rate changesInsider Buying & Daily Stock Momentum Reports - baoquankhu1.vn
Cue Biopharma (NASDAQ:CUE) Shares Up 9% – Should You Buy? - Defense World
Activity Recap: Whats the profit margin of Cue Biopharma IncJuly 2025 Short Interest & Low Drawdown Momentum Ideas - baoquankhu1.vn
Analyst Upgrade: Can Cue Biopharma Inc be recession proofJuly 2025 Snapshot & Daily Growth Stock Investment Tips - baoquankhu1.vn
Cue Biopharma launches proposed public offering of shares and warrants - MSN
Can Cue Biopharma Inc. stock outperform in 2025 bull marketWeekly Investment Recap & AI Driven Price Forecasts - Улправда
How sustainable is Cue Biopharma Inc. stock dividend payout2025 Growth vs Value & Short-Term Trading Alerts - Улправда
Why Cue Biopharma Inc. stock is trending among retail tradersStock Surge & Verified Momentum Stock Ideas - Улправда
What sentiment indicators say about Cue Biopharma Inc. stock2025 Pullback Review & Reliable Momentum Entry Alerts - Улправда
Aug Big Picture: Why Cue Biopharma Inc. stock remains resilient2025 Top Gainers & Consistent Return Strategy Ideas - Улправда
Why Cue Biopharma Inc. stock remains resilientJuly 2025 Highlights & Free Safe Capital Growth Stock Tips - Улправда
Will Cue Biopharma Inc. stock see insider buyingStop Loss Placement Tips & Small Entry Cost Investments - Улправда
Institution Moves: Will Cue Biopharma Inc 1UC stock benefit from mergersTrade Risk Assessment & AI Forecast Swing Trade Picks - Bộ Nội Vụ
Is Cue Biopharma Inc. stock attractive for growth ETFs2026 world cup usa national team semifinals top scorers high defensive line tactical prediction expert opinion - Улправда
2026 world cup lineups insights: Will Cue Biopharma Inc. stock benefit from AI adoption2026 world cup usa national team round of 32 young talents transition play tactical prediction insights - ulpravda.ru
EBIT per share of Cue Biopharma, Inc. – SWB:1UC - TradingView — Track All Markets
CUE Insider Trading - Quiver Quantitative
Is Cue Biopharma Inc a good long term investmentStock Screening Results & Big Gains Low Budget - earlytimes.in
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
Cue Biopharma stock: niche immunotherapy bet caught in a bruising small-cap biotech storm - AD HOC NEWS
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
Cue Biopharma (CUE) price target increased by 25.00% to 5.10 - MSN
Working capital per share of Cue Biopharma, Inc. – SWB:1UC - TradingView — Track All Markets
Cue Biopharma prices $10M underwritten public offering; shares down - MSN
Can Cue Biopharma Inc. stock rebound after recent weaknessTreasury Yields & Verified Swing Trading Watchlists - Улправда
How Cue Biopharma Inc. (1UC) stock reacts to stronger dollarMarket Activity Report & Risk Controlled Swing Trade Alerts - Улправда
Published on: 2025-12-20 23:54:48 - moha.gov.vn
Cue Biopharma Stock Drop Looks Sharp, But How Deep Can It Go? - Trefis
Cue Biopharma Signs Underwriting Agreement With H.C. Wainwright & Co. - TradingView — Track All Markets
Cue Biopharma prices $10 million public offering at $0.28 per share - Investing.com Nigeria
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
Cue Biopharma (CUE) Launches $10 Million Public Offering with Wa - GuruFocus
Cue Biopharma prices 35.7M shares at 28c in underwritten public offering - TipRanks
Cue Biopharma (CUE) Launches $10 Million Public Offering with Warrants - GuruFocus
Cue Biopharma announces pricing of $10 million public offering - marketscreener.com
Why retail investors pile into Cue Biopharma Inc. stock2025 Valuation Update & Safe Capital Growth Plans - ulpravda.ru
Cue Biopharma Announces Pricing of $10 Million Public Offering - GlobeNewswire
Cue Biopharma Inc (CUE) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.24%
0.19%
자본화:
|
볼륨(24시간):